Date of enactment: December 17, 1999
1999 Assembly Bill 357 Date of publication*: December 31, 1999
* Section 991.11, Wisconsin Statutes 1997-98: Effective date of acts. "Every act and every portion of an act enacted by the legislature over the governor's partial veto which does not expressly prescribe the time when it takes effect shall take effect on the day after its date of publication as designated" by the secretary of state [the date of publication may not be more than 10 working days after the date of enactment].
An Act to amend 961.14 (5) (ag) and 961.41 (3g) (f) of the statutes; relating to: the proper chemical name of the controlled substance gamma-butyrolactone (suggested as remedial legislation by the department of justice).
The people of the state of Wisconsin, represented in senate and assembly, do enact as follows:
Law revision committee prefatory note: This bill is a remedial legislation proposal, requested by the department of justice and introduced by the law revision committee under s. 13.83 (1) (c) 4., stats. After careful consideration of the various provisions of the bill, the law revision committee has determined that this bill makes minor substantive changes in the statutes, and that these changes are desirable as a matter of public policy.
21,1 Section 1. 961.14 (5) (ag) of the statutes is amended to read:
961.14 (5) (ag) Gamma-hydroxybutyric acid (commonly known as gamma hydroxybutyrate or "GHB") and gamma-hydroxybutyrolactone gamma-butyrolactone.
21,2 Section 2. 961.41 (3g) (f) of the statutes is amended to read:
961.41 (3g) (f) If a person possesses or attempts to possess gamma-hydroxybutyric acid, gamma-hydroxybutyrolactone gamma-butyrolactone, ketamine or flunitrazepam, the person may be fined not more than $5,000 or imprisoned for not more than 2 years or both.
Note: This bill changes the drug name gamma-hydroxybutyrolactone to gamma-butyrolactone. Gamma-hydroxybutrolactone is a chemical that is not being abused nor is it likely to be abused. Gamma-butyrolactone is a chemical that is used in the manufacture of gamma-hydroxybutyrate and gamma-hydroxybutyric acid and is also a drug in its own right. Listing gamma-butyralactone in the statutes will enable prosecution of offenses involving this drug.